Baby Aspirin & Cancer
Aspirin has long been touted as the go-to over-the-counter medication for patients with a long standing history of heart problems, or for those who want to use it prophylactically to protect against stroke. Now it is being considered as an aside to helping the fight against cancer.
British researchers compiled evidence from several studies that suggests that long term aspirin use tends to reduce the risk of certain cancers. The analysis was published online in the Annals of Oncology in August 2014.
In an August 12, 2014 New York Times article, it notes that a dosage of 75 to 81 milligrams of baby aspirin is an appropriate maintenance dosage since the long term benefit of cancer prevention outweighs the potential side effects of the drug. However, whenever medication is taken, particularly on a long term basis, even if it is aspirin, it is important for the patient to discuss the risks and benefits of doing so with his personal physician.
New York City medical malpractice attorney, Steven E. North, states that it is important for patients to establish an open line of dialogue with their personal physicians. Not only will such communication best serve the health and interest of the patient but it will also serve to protect the physician from being liable in a medical malpractice claim for negligence or lack of informed consent if an untoward event occurs.
Personal Injury Litigation
Medical Malpractice Law